|
| Exchange Received Time 01/02/2018 17:11:14 Exchange Disseminated Time 01/02/2018 17:11:19 Time Taken 00:00:05 | Dear Sir,
Pursuant to Regulation 29 read with Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby give notice that the meeting of the Board of Directors of the company is scheduled to be held on Friday, February 9th, 2018 inter-alia, to consider and approve the Unaudited Financial Results (Standalone) for the quarter ended 31st December, 2017.
Further , it is Informed that as per Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting by Insiders framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Trading window for dealing in the securities of the Company shall remain closed from Friday, February 2nd, 2018 to Thursday, 15th, February, 2018. (both days inclusive)..
This information is also be available on the Company's website at www.jagsonpal.com and on the website of BSE and NSE, where the Company's Equity Shares are listed.
Thanking you.
Yours faithfully,
for JAGSONPAL PHARMACEUTICALS LIMITED
R K KAPOOR
COMPLIANCE OFFICER CUM COMPANY SECRETARY
Dear Sir,
Jagsonpal Pharmaceuticals Limited informs BSE & NSE that Pursuant to the Code of Conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed for dealing in the securities of the Company for all the persons defined under the said Regulations including Director/Officer and Employees of the Company from Friday the 2nd, February, 2018 to Thursday, the 15th, February, 2018 from the date of declaration for the Un-audited Financial Results for the year quarter ended 31st December, 2017..
Thanking you.
Yours faithfully,
for JAGSONPAL PHARMACEUTICALS LIMITED
R K KAPOOR
COMPLIANCE OFFICER CUM COMPANY SECRETARY
|
|
|